Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

NCT02300571 · clinicaltrials.gov ↗
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fondazione del Piemonte per l'Oncologia